• Media type: E-Article
  • Title: Micronized Vaginal Progesterone to Prevent Miscarriage: A Critical Evaluation of Randomized Evidence
  • Contributor: Coomarasamy, Arri; Devall, Adam J.; Brosens, Jan J.; Quenby, Siobhan; Stephenson, Mary D.; Sierra, Sony; Christiansen, Ole B.; Small, Rachel; Brewin, Jane; Roberts, Tracy E.; Dhillon-Smith, Rima; Harb, Hoda; Noordali, Hannah; Papadopoulou, Argyro; Eapen, Abey; Prior, Matt; Di Renzo, Gian Carlo; Hinshaw, Kim; Mol, Ben W.; Lumsden, Mary Ann; Khalaf, Yacoub; Shennan, Andrew; Goddijn, Mariette; van Wely, Madelon; [...]
  • Published: Ovid Technologies (Wolters Kluwer Health), 2020
  • Published in: Obstetrical & Gynecological Survey, 75 (2020) 12, Seite 743-744
  • Language: English
  • DOI: 10.1097/ogx.0000000000000877
  • ISSN: 0029-7828; 1533-9866
  • Keywords: Obstetrics and Gynecology ; General Medicine
  • Origination:
  • Footnote:
  • Description: <jats:p>(Abstracted from <jats:italic toggle="yes">Am J Obstet Gynecol</jats:italic> 2020;223(2):167–176)</jats:p> <jats:p>Historically, a lack of methodologically strong and generalizable studies has limited policy makers from recommending the use of progesterone supplementation to improve outcomes in women at high risk of miscarriage. The PROMISE and PRISM trials were carried out to rectify this and generate robust evidence on the role of progesterone supplementation to prevent miscarriage.</jats:p>